Overview
- Editors:
-
-
Stephen C. Piscitelli
-
, Infectious Diseases, GlaxoSmithKline, Research Triangle Park, USA
-
Keith A. Rodvold
-
College of Pharmacy, Dept. Pharmacy Practice, University of Illinois, Chicago, Chicago, USA
-
Manjunath P. Pai
-
, Pharmaceutical Sciences, Albany College of Pharmacy, Albany, USA
- Definitive reference source of up-to-date information on antimicrobial drug interactions
- Informative tables on the degree of interaction for specific antimicrobial agents
- New chapters on non-HIV antiviral, antimalarial, antiparasitic, and macrolide, azalide and ketolide agents
Access this book
Other ways to access
Table of contents (20 chapters)
-
Front Matter
Pages i-xiii
-
-
- Kevin C. Brown, Angela D. M. Kashuba
Pages 11-41
-
- Catia Marzolini, Manuel Battegay, David Back
Pages 43-72
-
- Kelly Sprandel-Harris, Liz Yoo, Keith A. Rodvold
Pages 73-130
-
-
- Jenna O. McNeil, Kerry B. Goralski
Pages 167-201
-
- Larry H. Danziger, Melinda Neuhauser
Pages 203-242
-
-
-
- Mary A. Ullman, John C. Rotschafer
Pages 333-353
-
-
- Rocsanna Namdar, Charles A. Peloquin
Pages 401-424
-
- Sarah M. Robertson, Stephen C. Piscitelli, Kimberly A. Struble
Pages 425-470
-
-
- Paul O. Gubbins, Jarrett R. Amsden
Pages 509-560
-
- Sunil Parikh, Ming-Na Tina Lee, Francesca T. Aweeka
Pages 561-579
-
-
-
- Anne N. Nafziger, Joseph S. Bertino Jr., Joseph S. Bertino Jr.
Pages 631-653
About this book
The revised and up-to-date third edition of Drug Interactions in Infectious Diseases delivers a text that will enhance your clinical knowledge of the complex mechanisms, risks, and consequences of drug interactions associated with antimicrobials, infection, and inflammation. The third edition features five new chapters that cover material not addressed in previous editions. These new chapters describe interactions with a number of drug classes such as non-HIV antiviral, antimalarial, antiparasitic, antihelmintic, macrolide, azalide and ketolide agents. A novel chapter on probe cocktail studies has been included to highlight an important research tool for drug development. These chapters address material that cannot be retrieved easily in the medical literature. The highly acclaimed food-drug interactions as well as the study design and analysis chapters remain definitive references. The newly written drug-cytokine interaction highlights the need for our improved understanding of the complex interrelationship of acute infection, inflammation, and the risk of drug interactions. Informative tables on specific drug-drug interactions are provided throughout the chapters as a quick clinical resource. The Third Edition of Drug Interactions in Infectious Diseases is a distillation of relevant drug interactions associated with antimicrobials, infection, and inflammation. This concise review of the mechanisms and strategies to manage drug interactions should be valuable to all health care practitioners. Features • Definitive reference source of up-to-date information on antimicrobial drug interactions • Informative tables on the degree of interaction for specific antimicrobial agents • In-depth discussion of mechanisms and potential mechanistic pathways of interaction • New chapters on non-HIV antiviral, antimalarial, antiparasitic, and macrolide, azalide and ketolide agents • New chapter on probe-cocktail studies as a research tool to study drug-drug interactions • Inclusionof new antimicrobial agents and their associated drug interactions • First rate chapters on study design and analysis, and drug-food interactions • A fresh perspective on drug-cytokine interactions • Authoritative chapter on regulatory considerations of drug interactions during drug development
Editors and Affiliations
-
, Infectious Diseases, GlaxoSmithKline, Research Triangle Park, USA
Stephen C. Piscitelli
-
College of Pharmacy, Dept. Pharmacy Practice, University of Illinois, Chicago, Chicago, USA
Keith A. Rodvold
-
, Pharmaceutical Sciences, Albany College of Pharmacy, Albany, USA
Manjunath P. Pai
